Loading...
Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors
CTLA-4, PD-1, and PD-L1 monoclonal antibodies, commonly known as immune checkpoint inhibitors, are used for the treatment of various malignancies. The mechanism of action involves the inhibition of negative regulators of immune activation, which results in many patients developing immune-related adv...
Na minha lista:
| Udgivet i: | Br J Dermatol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459625/ https://ncbi.nlm.nih.gov/pubmed/27943234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15237 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|